Aspect Biosystems is pioneering microfluidic 3D bioprinting of living human tissue. Bioprinted tissue therapeutics falls at the intersection of cell biology, materials science, microfluidics and 3D printing and represents a paradigm shift in the traditional approach to regenerative medicine. Aspects biosystem uses microfluidic bioprinters and print heads with customizable biomaterials to generate first-in-class cell therapies.
Aspect is creating a targeted pipeline of tissue therapeutics to transform how we treat disease. They are implantable, allogeneic cell therapies that can take on different forms and perform a variety of functions. Aspect’s therapeutics have the potential to replace lost biological function, repair damaged tissue and provide localized therapeutic delivery.